Mesenteric vein thrombosis associated with intravaginal contraceptives: A case report and review of the literature

Journal of Thrombosis and Thrombolysis

Volumn 15, Issue 2, 2003, Pages 105-108

  Voora, Deepak ^a   Vijayan, Anitha ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case report; Contraceptives; Mesenteric veins; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS ETONOGESTREL; HEPARIN; WARFARIN;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DOPPLER FLOWMETRY; FAMILY HISTORY; FEMALE; HUMAN; MEDICAL LITERATURE; MENSTRUAL CYCLE; MESENTERIC VEIN THROMBOSIS; MYOMECTOMY; NEGRO; PEPTIC ULCER; PORTAL VEIN THROMBOSIS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; UTERUS MYOMA; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MESENTERIC VEINS; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS; WARFARIN;

EID: 0345602927     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000003323.80742.4d     Document Type: Article

References (20)

1. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1998;877(i-vii):1-89.
2. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344(20):1527-1535.
3. Hassan HA. Oral contraceptive-induced mesenteric venous thrombosis with resultant intestinal ischemia. J Clin Gastroenterol 1999;29(1):90-95.
4. Buccino G, Scoditti U, Pini M, Tagliaferri AR, Manotti C, Mancia D. Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: Evidence from a clinical series. Ital J Neurol Sci 1999;20(4):231-235.
5. Wu SM, Spurny OM, Klotz AP. Budd-chiari syndrome after taking oral contraceptives. A case report and review of 14 reported cases. Am J Dig Dis 1977;22(7):623-628.
6. Cravo MA, Marchesini JB, Chaves Luiz AA, Stahlke H, Jr., Busnardo AC. [Enteromesenteric infarct caused by contraceptives]. AMB Rev Assoc Med Bras 1975;21(5):138-140.
7. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346(8990):1589-1593.
8. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348(9033):977-980.
9. Warren SET. Mesenteric venous thrombosis. Surg Gynecol Obstet 1935;61:102-121.
10. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 2001;345(23):1683-1688.
11. FDA approves NuvaRing contraceptive implant. J Gend Specif Med 2002;5(2):6.
12. Banerjee S. Transdermal contraceptive patch - A new birth control option. Issues Emerg Health Technol 2001(26):1-4.
13. Mishell DR Jr., Talas M, Parlow AF, Moyer DL. Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate. Am J Obstet Gynecol 1970;107(1):100-107.
14. Odlind V. New delivery systems for hormonal contraception. Acta Obstet Gynecol Scand Suppl 1986;134:15-20.
15. Szarewski A. High acceptability and satisfaction with NuvaRing use. Eur J Contracept Reprod Health Care 2002;7(Suppl 2):31-36; Discussion 37-39.
16. Harward TR, Green D, Bergan JJ, Rizzo RJ, Yao JS. Mesenteric venous thrombosis. J Vasc Surg 1989;9(2):328-333.
17. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22(2):201-210.
18. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100(7):713-716.
19. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100(7):717-722.
20. Walsh BW, Paul S, Wild RA, et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial. J Clin Endocrinol Metab 2000;85(1):214-218.